Bioencapsulation Technologies in Tissue Engineering
Source abstract
Abstract
Bioencapsulation technologies have played an important role in the developing successes of tissue engineering. Besides offering immunoisolation, they also show promise for cell/tissue banking and the directed differentiation of stem cells, by providing a unique microenvironment. This review describes bioencapsulation technologies and summarizes their recent progress in research into tissue engineering. The review concludes with a brief outlook regarding future research directions in this field.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Electrohydrodynamics and Fluid Dynamics · Pancreatic function and diabetes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
BioMolecular Engineering Program, Department of Physics and Chemistry, Milwaukee School of Engineering, Milwaukee, Wisconsin - USA
Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, Wisconsin - USA
Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, Liaoning Province - PR China
Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Headington, Oxford - UK
Department of Biomedical Engineering, Wayne State University, Detroit, Michigan - USA
Department of Orthopedic Surgery, Providence Hospital and Medical Centers, Southfield, Michigan - USA
References (81)
Show source-provided references
1. 10.1517/17425247.2015.100136210.1517/17425247.2015.1001362 ↗
2. 10.1016/j.jconrel.2008.08.01010.1016/j.jconrel.2008.08.010 ↗
3. 10.1038/nm0103-10410.1038/nm0103-104 ↗
4. 10.1260/2040-2295.2.4.42710.1260/2040-2295.2.4.427 ↗
5. 10.1016/j.addr.2013.07.00910.1016/j.addr.2013.07.009 ↗
6. Zhang W · Archives of Stem Cell Research · 2015 · 2 · 1004
7. 10.1039/c3lc50678a10.1039/c3lc50678a ↗
8. 10.1039/c4ib00100a10.1039/c4ib00100a ↗
9. 10.1039/C2TB00058J10.1039/C2TB00058J ↗
10. 10.1021/bp050386n10.1021/bp050386n ↗
11. 10.1016/j.biomaterials.2009.03.00510.1016/j.biomaterials.2009.03.005 ↗
12. 10.1089/ten.tec.2009.066010.1089/ten.tec.2009.0660 ↗
13. 10.1007/s10544-009-9363-z10.1007/s10544-009-9363-z ↗
14. 10.1016/j.ejps.2012.06.01410.1016/j.ejps.2012.06.014 ↗
15. 10.1016/j.ijpharm.2015.02.04710.1016/j.ijpharm.2015.02.047 ↗
16. 10.1002/ppsc.20140000210.1002/ppsc.201400002 ↗
17. 10.5301/jabfm.500025010.5301/jabfm.5000250 ↗
18. ChangTMS Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy. Vol. 1 Singapore: World Scientific Publishing; 2007.10.1142/9789812770370 ↗
19. 10.1111/j.1582-4934.2010.01189.x10.1111/j.1582-4934.2010.01189.x ↗
20. 10.1098/rsif.2014.081710.1098/rsif.2014.0817 ↗
21. 10.1080/1465324070176237210.1080/14653240701762372 ↗
22. 10.1016/j.tips.2015.05.00310.1016/j.tips.2015.05.003 ↗
23. ZhangW Encapsulation of transgenic cells for gene therapy, Gene Therapy: principles and challenges. In: Hashad D, ed.InTech; InTech: Rijeka, Croatia 2015.10.5772/61050 ↗
24. 10.1007/978-1-4419-5786-3_210.1007/978-1-4419-5786-3_2 ↗
25. 10.1002/jbm.a.3520510.1002/jbm.a.35205 ↗
26. 10.1016/j.actbio.2013.12.00610.1016/j.actbio.2013.12.006 ↗
27. 10.1039/C4TB01241K10.1039/C4TB01241K ↗
28. Park HS · J Tissue Eng Regen Med
29. 10.1038/leu.2012.20210.1038/leu.2012.202 ↗
30. 10.1089/ten.teb.2015.014010.1089/ten.teb.2015.0140 ↗
31. 10.1111/j.1399-3089.2007.00384.x10.1111/j.1399-3089.2007.00384.x ↗
32. CellMedAG GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-Occupying Intracerebral Hemorrhage. NCT01298830. http://www.clinicaltrials.gov. Accessed May 13, 2016.
33. Living Cell Technologies. Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease. Disease (NCT01734733) and Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease (NCT02683629). http://www.clinicaltrials.gov. Accessed May 13, 2016.
34. 10.1089/ten.tea.2010.023410.1089/ten.tea.2010.0234 ↗
35. 10.1155/2012/86179410.1155/2012/861794 ↗
36. 10.1016/j.addr.2013.11.00510.1016/j.addr.2013.11.005 ↗
37. 10.1039/C4CS00483C10.1039/C4CS00483C ↗
38. 10.1038/srep0980610.1038/srep09806 ↗
39. 10.1002/mabi.20150011010.1002/mabi.201500110 ↗
40. 10.1039/c3bm00166k10.1039/c3bm00166k ↗
41. 10.1016/j.biomaterials.2013.09.07110.1016/j.biomaterials.2013.09.071 ↗
42. 10.1021/bc900494x10.1021/bc900494x ↗
43. 10.1016/j.ijbiomac.2015.03.06110.1016/j.ijbiomac.2015.03.061 ↗
44. DumbletonJ AgarwalP HuangH et al. The effect of RGD peptide on 2D and miniaturized 3D culture of HEPM cells, MSCs, and ADSCs with alginate hydrogel. Cell Mol Bioeng. 2016 [Epub ahead of print].10.1007/s12195-016-0428-9 ↗
45. 10.1016/j.reth.2016.03.00410.1016/j.reth.2016.03.004 ↗
46. 10.1039/C2BM00048B10.1039/C2BM00048B ↗
47. 10.1016/j.biomaterials.2013.12.07310.1016/j.biomaterials.2013.12.073 ↗
48. 10.1115/1.315332610.1115/1.3153326 ↗
49. 10.1016/j.addr.2013.07.02110.1016/j.addr.2013.07.021 ↗
50. 10.1016/j.addr.2013.09.01510.1016/j.addr.2013.09.015 ↗
51. 10.3109/0265204030917807110.3109/02652040309178071 ↗
52. 10.1080/0265204021014424310.1080/02652040210144243 ↗
53. 10.1080/0265204011010532810.1080/02652040110105328 ↗
54. 10.1063/1.490294310.1063/1.4902943 ↗
55. 10.1039/b819044e10.1039/b819044e ↗
56. BÜCHI LabortechnikAG Encapsulator B-390: the valued bead and capsule producer [company website page]. Flawi, Switzerland: BÜCHI Labortechnik AG. http://www.buchi.com/en/products/spray-drying-and-encapsulation/encapsulator-b-390. Accessed May 13, 2016.
57. Cellena. Portable microencapsulation equipment Cellena® [company website page]. Sevilla, Spain: Ingeniatrics Technologies. http://www.cellena.net/en/portable_microencapsulation_equipment_cellena.html. Accessed May 13, 2016.
58. 10.1016/j.eurpolymj.2015.02.03810.1016/j.eurpolymj.2015.02.038 ↗
59. 10.1016/j.actbio.2012.05.01610.1016/j.actbio.2012.05.016 ↗
60. 10.1161/JAHA.113.00036710.1161/JAHA.113.000367 ↗
61. 10.1016/j.biomaterials.2013.09.08510.1016/j.biomaterials.2013.09.085 ↗
62. 10.3727/096368910X51395510.3727/096368910X513955 ↗
63. 10.3727/00000000878390710710.3727/000000008783907107 ↗
64. 10.1097/01.tp.0000261104.27113.0510.1097/01.tp.0000261104.27113.05 ↗
65. 10.1016/j.jbiosc.2014.09.02310.1016/j.jbiosc.2014.09.023 ↗
66. 10.5966/sctm.2013-007510.5966/sctm.2013-0075 ↗
67. 10.1089/ten.tea.2015.006910.1089/ten.tea.2015.0069 ↗
68. 10.1126/scitranslmed.300597510.1126/scitranslmed.3005975 ↗
69. 10.1089/ten.tec.2009.037410.1089/ten.tec.2009.0374 ↗
70. 10.3748/wjg.v17.i7.93810.3748/wjg.v17.i7.938 ↗
71. 10.3109/1465324090312127810.3109/14653240903121278 ↗
72. 10.1021/nl400774410.1021/nl4007744 ↗
73. 10.1002/adfm.20150304710.1002/adfm.201503047 ↗
74. 10.1016/j.jconrel.2013.04.01510.1016/j.jconrel.2013.04.015 ↗
75. 10.1038/srep0685610.1038/srep06856 ↗
76. 10.1016/j.actbio.2008.01.00710.1016/j.actbio.2008.01.007 ↗
77. 10.1016/j.bbagen.2015.04.01110.1016/j.bbagen.2015.04.011 ↗
78. 10.1007/s10544-011-9623-610.1007/s10544-011-9623-6 ↗
79. 10.1016/j.biomaterials.2014.10.03210.1016/j.biomaterials.2014.10.032 ↗
80. 10.1089/ten.tec.2009.054510.1089/ten.tec.2009.0545 ↗
81. 10.1016/j.addr.2011.03.00410.1016/j.addr.2011.03.004 ↗